Experts Discuss Key Topics in Treatment for Newly Diagnosed Multiple Myeloma

In this podcast episode, Jesus G. Berdeja, MD, and Ajai Chari, MD, discuss evolving therapy in newly diagnosed multiple myeloma, including:

• Selecting quadruplet therapy
• Optimal use of bortezomib
• The role of autologous stem cell transplantation in the quadruplet era
• Use of MRD status to inform treatment decisions
• Maintenance strategies

 Presenters:

Jesus G. Berdeja, MD
Director of Myeloma Research
Greco-Hainsworth Centers for Research 
Partner
Tennessee Oncology
Nashville, Tennessee

Ajai Chari, MD
Professor of Clinical Medicine
Director of Multiple Myeloma Program
UCSF Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco (UCSF) Medical Center
San Francisco, California

Content based on an online CME program supported by an educational grant from GSK.

Link to full program: 
https://bit.ly/4yTeLZD

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Oncology Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.